Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease
This study is ongoing, but not recruiting participants.
Sponsor:
Avraham Pharmaceuticals Ltd
Information provided by (Responsible Party):
Avraham Pharmaceuticals Ltd
ClinicalTrials.gov Identifier:
NCT01354691
First received: May 1, 2011
Last updated: February 23, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2013 |
| Estimated Primary Completion Date: | September 2012 (Final data collection date for primary outcome measure) |